The patent claim describes the ingredient as a method of improving non-alcoholic fatty liver disease in patients in need of treatment, comprising the administration of a composition containing glutathione as its active ingredient, wherein the non-alcoholic fatty liver disease is indicated by low liver stiffness.
Methionine, inositol, and choline are lipotropic agents associated with fat metabolism in the liver, and the added B12 supports energy metabolism and methylation
Int J Epidemiol 2013;42:1702-13
Supplementation should always be integrated into a broader protocol that includes aggressive pacing to manage post-exertional malaise, careful symptom tracking, dietary modifications to support histamine clearance, and ongoing medical care from specialists who truly understand the interconnected nature of neuro-immune diseases
This open-label trial (50 patients) aims to optimize dosing and evaluate safety/efficacy of the combo approach, with topline results expected by end of 2024
Discussion Sperm glycocalyx consists of more than 300 different glycoproteins and glycolipids